FMD

EU Hub: Final Countdown for Onboarding

The Adents Team Written by The Adents Team
12-Jan-2018

A new communiqué from the European Medicines Verification Organisation stresses the urgency for pharmaceutical companies to intensify compliance efforts regarding the Falsified Medicines Directive (2011/62/EU).

The European Medicines Verification Organisation urges pharmaceutical companies to get up to speed with their serialization compliance efforts.

June 2018 Deadline

According to the EMVO, “the end of June 2018 should be considered as the very last opportunity to on-board timely”. This means, pharmaceutical companies need to choose their level 4 serialization solution and their OBP-Gateway-Provider* within the next 6 months.  “Any late on-boarding after that date may entail a risk to the company’s business” warns the organization.

Enterprise-level solutions to ensure correct data 

Choosing a level 4 solution provider that is certified as an official OBP Gateway Provider for the European Hub can greatly facilitate onboarding as certified companies have experts who know all about the technical onboarding process. However, it is very important to first and foremost choose the right enterprise-level serialization solution to ensure that your unique serial numbers are centralized in one platform to avoid duplicates across lines and sites before even thinking of being able to report them to the EMVS. Only if you can ensure correct data you can ensure compliant reporting. Furthermore, your serialization solution needs to be able to export relevant serialization and product master data in the correct format required by authorities.

Your solution for clean data and compliant reporting

Certified for the European Hub, Adents Prodigi can ensure both: storage and indexation of all serial numbers across your production sites to avoid duplicates no matter whether the codes are generated – centrally with Prodigi or by your CMOs and production sites – and reporting of correct data in the correct format.

Need more info or a product demo?

*According to EMVO’s definition, an OBP (onboarding partner) “is a legal entity that is part of a Corporation or a Group and will send data to the EU Hub on behalf of Marketing Authorization Holders that are also part of that corporation”. In short, this means an entity of a pharmaceutical group or company that centralizes all serialization data and reports it in the required format to the relevant European authority (through the Hub).

The Adents Team
The Adents Team

The Adents Team: your serialization experts. With over 25 years of experience in different fields of product traceability, supply chain, big data and pharmaceutical serialization, our team members bring a wealth of knowledge to help you better understand the challenges and opportunities of serialization.

DISCOVER MORE ...

EU FMD: new FAQ document gives guidance on safety features for medicinal products
EU FMD: new FAQ document gives guidance on safety features for medicinal products
The EU commission has released version 16 of the FAQS related to the EU Falsified Medicines Directive including recommendations on coding requirements and serial number generation.
FDA delays Product Identifier verification requirement for saleable returns
FDA delays Product Identifier verification requirement for saleable returns
The FDA issued a compliance policy guidance for Wholesale Distributor Verification Requirement for Saleable Returned Drug Product in the US. The deadline is now November 27th 2020.